Aspect Biosystems to Present at 2023 Cell & Gene Meeting on the Mesa
VANCOUVER, BC — Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics, announced today that CEO Tamer Mohamed will present at the annual Cell & Gene Meeting on the Mesa to be held October 10-12, 2023 in Carlsbad, California and livestreamed globally.
Organized by the Alliance for Regenerative Medicine, the Cell & Gene Meeting on the Mesa is a three-day conference featuring more than 120 dedicated company presentations by leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering, and broader regenerative medicine technologies, as well as over 100 panelists and featured speakers.
The following are specific details regarding Aspect Biosystems’ presentation at the conference:
|2023 Cell & Gene Meeting on the Mesa
|Tuesday, October 10, 2023
|Park Hyatt Aviara Resort,
7100 Aviara Resort Dr.,
Carlsbad, CA 92011
Virtual attendance is available which includes a livestream of Aspect’s presentation and the ability to view all conference sessions on-demand. Please visit https://meetingonthemesa.com for full information including registration.
About Aspect Biosystems
Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat currently incurable diseases. Aspect is creating these next generation cell therapies by applying its full-stack tissue therapeutic platform, which combines the company’s proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body with the aim of treating currently incurable diseases such as type 1 diabetes as well as genetic and acquired liver diseases. Learn more at www.aspectbiosystems.com.
Original source here.